Results 31 to 40 of about 26,977 (247)
Introduction Implantable cardioverter defibrillators register various types of arrhythmias. Thus they can be exploited to better identify patients with atrial fibrillation episodes and increase the proportion of patients who may benefit from ...
Barbara Dominik +4 more
doaj +1 more source
ABSTRACT Background Hypertrophic cardiomyopathy is associated with alterations in coronary microvascular function which have variable pathophysiologic mechanisms, and variable reversibility acutely and chronically following alcohol septal ablation (ASA).
Vojko V. Misevic +12 more
wiley +1 more source
Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
Introduction: The implantable cardioverter defibrillator had been increasing the survival of patients at high risk for sudden cardiac death. The subcutaneous implantable cardioverter defibrillator was developed to mitigate the complications inherent to ...
Fernando Sérgio Oliva Souza +6 more
doaj +1 more source
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray +2 more
wiley +1 more source
Automated Implantable Cardioverter Defibrillators (AICD), simply known as an Implantable Cardioverter Defibrillator (ICD), has been used in patients for more than 30 years.
Altaf Hussain Shah +2 more
doaj +1 more source
S-ICD Implantation "Tips and Tricks"
An implantable cardioverter-defibrillator (ICD) was developed to provide protection against sudden cardiac death. Despite being effective in terminating ventricular arrhythmias, traditional transvenous ICDs appeared over time to have certain limitations ...
Szymon Budrejko +2 more
doaj +1 more source
Erosion of an Implantable Cardioverter-Defibrillator
![Figure][1] A 51-year-old man with previous myocardial infarction received a single-chamber implantable cardioverter-defibrillator (ICD) in 2002 for syncope and inducible ventricular tachycardia at electrophysiologic testing.
Elmouchi, Darryl, Woelfel, Alan
openaire +2 more sources
Forecasting heart failure: Seasonal alignment of heart failure outcomes in New York
Abstract Background Seasonal variations have been observed in heart failure (HF) hospitalization. Numerous explanatory mechanisms have been proposed, but no prior studies have examined potential contributors directly. Our objective was to identify specific factors that could contribute to seasonal variability using a large longitudinal dataset of HF ...
Prerna Gupta +5 more
wiley +1 more source
“Add-on pacing lead”: An effective and safe alternative to lead replacement in ICD pacing failure
Despite recent advances in implantable cardioverter defibrillator (ICD) technology, the long-term reliability of ICD leads remains a significant problem.
Sudeep Kumar +2 more
doaj +1 more source
Abstract Socio‐economic status (SES) has been associated with incident and prevalent heart failure (HF), as well as its morbidity and mortality. However, the precise nature of the relationship between SES and HF remains unclear due to inconsistent data. This study aims to provide a comprehensive assessment and data synthesis of the relationship between
Abdul Shakoor +8 more
wiley +1 more source

